REGENERON
Live / Registered — Registered and renewed (as of 03 Mar 2024)
What this means for you
Registered since 17 Sept 2013. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Sept 2023).
Record
- Serial number
- 85775911
- Registration number
- 4402744
- Mark type
- Stylized text
- Filed
- 09 Nov 2012
- Published for opposition
- 02 Jul 2013
- Registered
- 17 Sept 2013
- Next maintenance due
- 17 Sept 2023
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrrytown, NY, US
Prior registrations
Prosecution history
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 01 Nov 2024 — SEC. 15 ACKNOWLEDGEMENT - E-MAILED
- 01 Nov 2024 — REGISTERED - SEC. 15 ACKNOWLEDGED
- 01 Nov 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 02 Aug 2024 — TEAS SECTION 15 RECEIVED
- 03 Mar 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 03 Mar 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 03 Mar 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 02 Mar 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Sept 2023 — TEAS SECTION 8 & 9 RECEIVED
- 17 Sept 2022 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED